VILLEJUIF, France -Thursday, August 10th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- WIN Consortium (WIN) received the US Food and Drug Administration (FDA)’s approval to start the clinical investigation of a novel therapeutic approach using a combination of three targeted therapies for the first line treatment of patients with advanced Non Small Cell Lung Cancer (NSCLC). The Survival Prolongation by Rationale Innovative Genomics (SPRING) trial will aim to enroll patients who are usually offered first line platinum-based chemotherapy. Patients with documented targetable driver alterations (EGFR mutations, ALK rearrangements, ROS1 and MET exon 14 skipping mutations) will be excluded. The population of NSCLC patients without actionable oncogenic driver mutations, envisioned for the enrollment in SPRING trial, represents the vast majority of patients with metastatic NSCLC (~80% in the Caucasian population).

With over 60% of NSCLC detected in an advanced o ... Read more »

CHICAGO -Thursday, August 10th 2017 [ AETOS Wire ]

(BUSINESS WIRE)-- BAI announced the finalists for the BAI Global Innovation Awards, a prestigious awards program celebrating innovation in the financial services industry. Winners will be announced at BAI Beacon in Atlanta on October 4-5.

The BAI Global Innovation Awards recognizes industry leaders changing the industry and positively impacting profitability, efficiency and customer experience. Since 2011, BAI’s Global Innovation Awards has grown from two to 10 categories plus three special awards recognizing outstanding achievements across the primary Awards categories. Nominations are evaluated by the Innovation Circle Judging Panel, a worldwide roster of leaders who carefully weigh each application to uncover the brightest in innovative offerings based on originality and the impact to consumers and the industry.

The 2017 BAI Global Innovation Awards finalists are:

Product and S ... Read more »